eChapters

Aim

To synthesize gold (Au) nanoparticle using fungal mycelium.

Introduction

Biosynthesis of nanoparticles is a kind of bottom up approach where the main reaction occurring is reduction/oxidation. The fungal enzymes are usually responsible for reduction of metal compounds into their respective nanoparticles.

The history of nanotechnology in the modern world dates back to 1959 when American physicist Richard Feynman inspired the scientific community in his lecture “There is a plenty of rooms at the bottom”. Research on nanosized particles dramatically developed into an important field of modern research with potential effects in electronics to medicine and recently in agriculture and food industry.

Nanoparticles exhibit unique properties in terms of chemical, physical, photoelectrochemical and electronic properties when compared to their respective bulk materials. The applications of these nanosized particles are defined in a bigger ways in the field of Biotechnology. All these applications require custom based synthesis methods for specific applications.

Aim

To synthesize phosphorus (P) nanoparticles from tricalcium phosphate using fungal mycelium.

Introduction

Green nanotechnology includes a range of processes that reduce or eliminate toxic substances to restore environment. Microorganisms like fungi and bacteria having naturally bestowed property of reducing and oxidizing nanoparticles, are used for synthesis.

8.1 Introduction

Nanotechnology is the manoeuvring or self-assembly of individual atoms, molecules, or molecular clusters into structures to craft materials with new properties. The definition of nanotechnology is based on the prefix “nano” which is from the Greek word meaning “dwarf”. In more technical terms, the word “nano” means 10^-9, or one billionth of something. The word nanotechnology is generally used when referring to materials with the size of 1 to 100 nanometres, which is true for metallic nano-material. In case of polymeric nano-material, size may reach 600 nm, as polymeric materials are larger in size compression to metallic material. Nano-materials have different properties from bulk materials as a result of their size. These differences include physical strength, chemical reactivity, electrical conductance, magnetism, and optical effects (Schmid, 2006).

Biometrical genetics: This is a branches of genetics which uses the statistical concept and procedures for the study of genetic principles.

Biostatistics are the development and application of statistical methods to a wide range of topics in biology. It encompasses the design of biological experiments, the collection and analysis of data from those experiments and the interpretation of the results.

Quantitative traits are polygenic meaning they are controlled by many genes and gene interactions. Examples: height, weight, length etc.

Qualitative character

Qualitative traits are under the controlled of one or few genes, also called oligogeneic traits. For example, black or red coat color, horned or polled, coat color dilution, leaf color are all qualitative traits.

Biochemistry: An Overview of Biomolecules Biochemistry is a branch of science that delves into the chemical composition and interactions of cells and organisms. It focuses on the molecular structures found within biological systems, their chemical characteristics, functions, and the reactions they undergo. By studying these molecules, biochemists gain insights into the fundamental processes that sustain life. Properties of Biomolecules General Characteristics Biomolecules are fundamentally organic compounds, sharing similar properties with typical organic molecules. They obey the same physical and chemical principles, undergo similar reactions, and adhere to universal physical laws. However, their complexity and biological specificity distinguish them from simpler organic compounds. Composition and Structural Features The backbone of biomolecules is predominantly composed of carbon, which forms four covalent bonds, often exhibiting a tetrahedral geometry. Carbon skeletons can exist in diverse forms like linear,

7.1. BioNET International

7.1.1. What is BioNet International

BioNET-International, is the Global Network for Taxonomy, and is dedicated to creating sustainable mechanisms to assist developing countries to overcome the Taxonomic Impediment by becoming self-reliant in taxonomy i.e. self-reliant in the skills, infrastructure (collections etc.) and technologies needed to discover, identify, name and classify and to understand the relationships of all organisms on this planet.

It is concerned with helping developing countries to recognise and know the organisms that constitute and threaten their biodiversity, not for taxonomy’s own sake, but rather to support national programmes for sustainable agricultural development, and conservation and sustainable use of the environment.

BioNET-International is particularly focused on helping countries implement the various environmental conventions such as the International Plant Protection Convention (IPPC; www.ippc.int) and the Convention on Biological Diversity (CBD; www.biodiv.org), especially its taxonomic capacity building compnent, the Global Taxonomy Initiative (GTI). The subregional networks of BioNET-International have been identified as appropriate structures through which much of the GTI (www.biodiv.org/programmes/cross-cutting/taxonomy/default.asp) can be effectively implemented.

15.1 Biopiracy – Definition, Examples, and Impacts
Introduction
Biopiracy represents a grave ethical and legal concern in the field of biotechnology and intellectual property rights. It refers to the unauthorized and uncompensated exploitation of biological resources and traditional knowledge—primarily from developing countries—by corporations, research institutions, or individuals, often for commercial gains. Biopiracy is inherently unjust as it involves the misappropriation of community knowledge, undermining the rights of indigenous peoples, and violating the principles of equity, fairness, and sovereignty over natural resources.
As globalization intensifies biotechnological exploration, biopiracy challenges ethical norms and highlights the need for strong legal, institutional, and ethical safeguards.
Definition of Biopiracy
Biopiracy can be defined as:
“The unauthorized extraction, use, and commercialization of genetic resources or associated traditional knowledge from indigenous communities or biodiversity-rich regions without prior informed consent or fair and equitable benefit sharing.”
Biopiracy often involves patenting biological materials or indigenous medicinal knowledge without recognizing the origin communities as rightful holders of such knowledge or genetic wealth. It is closely linked to ethical misappropriation, exploitation, and violations of bioethical norms and international agreements.

Introduction

Several hazardous chemicals, microbes, and techniques like recombinant DNA technology are used for research and development work in research Institutes and universities. Therefore, the researchers, technical, helping and supporting staffs as well as the laboratory outputs must be kept free from contaminations. Thus, biosafety is necessary to prevent unintentional exposure/ release of hazardous chemicals, microbes/pathogens, and toxins to the laboratory staff and environment. Following the biosafety guidelines and ethical considerations are essential to maintain safety standards for the researchers as well as the environment. This chapter deals with various biosafety measures and ethical issues to be strictly followed while working in a research laboratory. The required safety level needs to be determined as per the chemical/biological materials are used in the laboratory to keep the researcher/environment safe for sustainable research and developmental activities.

Biosafety

The term biosafety is used to describe the procedure and policies needed to ensure environmental and personal safety. Biosafety refers to the containment principles, technologies and practices that are implemented to prevent unintentional exposure to pathogens, toxins, or their accidental release into the environment. A fundamental objective of any biosafety program is the containment of potentially harmful chemical/biological agents as precautionary safety measures.

Why Biosafety?

With the increasing number of countries adopting molecular biology tools and techniques in life science research and development activities, especially in the areas of agriculture and medicine, the biosafety issues are gaining importance to ensure biological safety for the public and the environment. Conducting research in safe and sustainable manner is not only a personal requirement but essential collective efforts to ensure biological safety for a clean and safe environment. This requires rules, regulations, monitoring bodies, and awareness among the workers as well as the public. Therefore, biosafety per se is an integral part of laboratory research and requires awareness among the researchers so that biological safety can be well taken care from the grassroot level.

Words like rDNA (recombinant DNA) technology, cloning, genetically modified organism (GMO), living modified organism (LMO) and transgenics are of today’s common knowledge. However rather than scientific interest, debates on biosafety issues have made these terms more agnized among general people. Global, sectorial and individual protests against transgenic plants and animals are enunciated allover the world raising issues and concerns over risks and health hazards of using these organisms. Despite these protests and concerns, commercial use of transgenic organism as food, feed or other purposes are increasing at an exponential rate. Although there is not much scientific evidence where transgenics have caused havocs on ecological balance or human health, the biosafety issues need to be solved to provide a safer environment rather than be sorry and lament in the future for today’s mistakes. One of the major problems in supporting use of GMOs lies in the incapability of biosafety science to draw reliable and widely acceptable conclusions for labeling a safe tag on these organisms and their derivatives.

Introduction
 
Nanotoxicity is a serious concern to be addressed sooner than later as nano-based processes and products in various fields are being extensively exploited. Nanotoxicology is the science of engineered nanodevices and nanostructures that deals with their effects in living organisms (Oberdorster et al., 2005). The unique property of nanoparticles is in its very large surface area to mass ratio, which is considered to be a boon to create novel products. But this distinctive property also challenges the way we identify, understand and address potential risks caused by nanoparticles (Rajkishore et al., 2011). It is sufficient to alert us to the fact that some engineered nanoparticles do indeed behave differently to their more conventional counterparts and may present new and unusual risks. Kahru and Dubourguier (2010) assessed the existing literature on nanotoxicity to main food chain levels (bacteria, algae, crustaceans, ciliates, fish, yeasts and nematodes) and classified the NPs of Ag and ZnO as “extremely toxic”, C60 fullerenes and CuO NP as “very toxic”, SWCNTs and MWCNTs as “toxic” and TiO₂ NP as “harmful”. 

9.1 The Cartagena Protocol on Biosafety: Objectives and Implementation
9.1.1 Introduction
The Cartagena Protocol on Biosafety (CPB) is a pivotal international legal instrument under the Convention on Biological Diversity (CBD), dedicated to regulating the transboundary movement, handling, and use of living modified organisms (LMOs) derived through modern biotechnology that may adversely affect biological diversity, human health, or the environment. Adopted in January 2000 in Cartagena, Colombia, and entering into force on September 11, 2003, the Protocol represents a global consensus on biosafety governance amidst the rapid expansion of genetic engineering technologies.
9.1.2 Objectives of the Cartagena Protocol
The principal objective of the Cartagena Protocol is:
“To contribute to ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements.” (Article 1, CPB)
The core objectives can be summarised as
• Ensuring biosafety in the context of international trade of LMOs.
• Protecting biodiversity from potential risks posed by LMOs.
• Safeguarding human health against unintended exposure to transgenic organisms.

Biotechnology has the potential to revolutionize many aspects in our lives, from healthcare to agriculture. However, along with its benefits, it also poses significant risks to human health, environment, and ecology. Therefore, it is essential to establish biosafety regulations and risk assessment frameworks to promote safe and responsible use of biotechnology. This chapter compiled an overview of biotechnology, the importance of biosafety regulations and risk assessment, IPR protection, contaminants, risk analysis, risk management in laboratories and fields, biosafety concerns to human health, environment and ecology, biosafety at international and national levels, bioethics, and general principles.

Overview of Biotechnology and its Potential Benefits and Risks

Biotechnology refers to the use of living organisms or their components to develop products and processes for various fields such as healthcare, agriculture, and environmental remediation. Biotechnology applications include genetic engineering, bioremediation, biopharmaceuticals, and biobased products.

8.1 Steps in Biosafety Risk Assessment
8.1.1 Introduction
Biosafety Risk Assessment is a systematic, science-based process used to identify, evaluate, and mitigate risks associated with handling biological agents, genetically modified organisms (GMOs), and biotechnological products. It is central to ensuring human safety, environmental integrity, and regulatory compliance in both laboratory and field applications.
A well-conducted biosafety risk assessment enables institutions to establish appropriate biosafety levels, implement containment measures, and ensure sustainable and responsible use of biotechnological advancements.
8.1.2 Key Objectives of Biosafety Risk Assessment
• Prevent exposure of personnel to biohazards.
• Avoid environmental contamination and unintended gene flow.
• Determine containment requirements for biological agents.
• Guide institutional and national biosafety decision-making.
• Support regulatory frameworks and compliance obligations.

13.1 Biosafety

Biosafety is the prevention of large-scale loss of biological integrity, focusing both on ecology and human health. These prevention mechanisms include conduction of regular reviews of the biosafety in laboratory settings, as well as strict guidelines to follow. Biosafety is used to protect from harmful incidents. Many laboratories handling biohazards employ an ongoing risk management assessment and enforcement process for biosafety. Failures to follow such protocols can lead to increased risk of exposure to biohazards or pathogens. Human error and poor technique contribute to unnecessary exposure and compromise the best safeguards set into place for protection. The international Cartagena Protocol on Biosafety deals primarily with the agricultural definition but many advocacy groups seek to expand it to include post-genetic threats: new molecules, artificial life forms, and even robots which may compete directly in the natural food chain.

Introduction

Biosensor technology is a powerful alternative to conventional analytical techniques, harnessing the specificity and sensitivity of biological systems in small, low cost devices. Despite the promising biosensors developed in research laboratories, there are not many reports of applications in agricultural monitoring. The authors review biosensor technology and discuss the different bio-receptor systems and methods of transduction. The difference between a biosensor and a truly integrated biosensor system are defined and the main reasons for the slow technology transfer of biosensors to the market place are reported. Biosensor research and development has been directed mainly towards health care, environmental applications and the food industry. The most commercially important application is the hand-held glucose meter used by diabetics. The agricultural / veterinary testing market has seen a number of diagnostic tests but no true biosensor systems have made an impact.

Abstract

Soil microorganisms play a major role in the biodissolution of nutrients bound in the soil silicate minerals. Plant nutrients like K, P, Ca, Mg, Fe, Zn, and Mn are bound in them. Silicon is considered as agronomically important as it confers rigidity and strength to crop plants and enhances yield. Biodissolution of these nutrients result in their availability to crops influencing the growth, biomass and yield. The microbial metabolites like organic acids, amino acids, inorganic acids, amines, ammonia, phenolic compounds, extracellular polysaccharides, siderophores, ligands of cations and cation exchange are involved in the biodissolution of K, Zn and Si. Frateuria aurantia, Bacillus mucilaginosus and B. edaphicus and Bacillus sp are recognized as potash mobilizers, silica and zinc solubilizers.

Tissue culture consists of growing plants cells as relatively on organized masses of cells on an agar medium (callus culture) or as a suspension of free cells and small cell masses in a liquid medium (suspension culture). In other words, In plant cell culture, plant tissues and organs are developed in vitro on artificial media, under aseptic and controlled environment. The procedure depends mainly on the concept of totipotentiality of plant cells (Haberlandt, 1902) which refers to the ability of a single cell to express the full genome by cell division.

Summary

Stem cells are undifferentiated cells which have the potential to divide and multiply indefinitely and can be differentiated to any type of cell of the body of an organism. Due to its peculiar characteristics stem cells are being experimentally used to cure certain dreaded diseases of the humans including different haemoglobinopathies. The stem cells isolated from bone marrow have been cultured, modified and differentiated to get various blood cells like erythrocytes, leukocytes, and thrombocytes etc. Recently haematopoietic stem cells have been transplanted to the sickle cell and beta thalassaemia patients successfully. Gene therapy using the embryonic and cord blood stem cells have been experimentally tried successfully to cure transgenic sickle as well as thalassaemic mice. Induced Pluripotent stem cells (iPS) generated from autologous skin has also been used successfully for treatment of transgenic sickle cell anaemia mouse.